Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin
about
The Legionella pneumophila IcmSW complex interacts with multiple Dot/Icm effectors to facilitate type IV translocationThe major iron-containing protein of Legionella pneumophila is an aconitase homologous with the human iron-responsive element-binding proteinExploring anti-bacterial compounds against intracellular LegionellaRNA interference analysis of Legionella in Drosophila cells: exploitation of early secretory apparatus dynamics.Legionella pneumophila exploits PI(4)P to anchor secreted effector proteins to the replicative vacuole.Evasion of Legionella pneumophila from the bactericidal system by reactive oxygen species (ROS) in macrophages.Transcriptional down-regulation and rRNA cleavage in Dictyostelium discoideum mitochondria during Legionella pneumophila infectionIdentification of Legionella pneumophila genes required for growth within and killing of human macrophagesLegionella pneumophila catalase-peroxidases: cloning of the katB gene and studies of KatB functionIn vitro activities of fleroxacin against clinical isolates of Legionella spp., its pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumoniaEarly events in phagosome establishment are required for intracellular survival of Legionella pneumophilaCatalase-peroxidases of Legionella pneumophila: cloning of the katA gene and studies of KatA function.Pathogen effector protein screening in yeast identifies Legionella factors that interfere with membrane traffickingLegionnaires disease: historical perspectiveThe Legionella pneumophila effector VipA is an actin nucleator that alters host cell organelle trafficking.Human and guinea pig immune responses to Legionella pneumophila protein antigens OmpS and Hsp60.Planktonic replication is essential for biofilm formation by Legionella pneumophila in a complex medium under static and dynamic flow conditions.Asc-dependent and independent mechanisms contribute to restriction of legionella pneumophila infection in murine macrophages.Legionella pneumophila catalase-peroxidases are required for proper trafficking and growth in primary macrophagesMinimization of the Legionella pneumophila genome reveals chromosomal regions involved in host range expansion.Comparative postantibacterial activities of pefloxacin, ciprofloxacin, and ofloxacin against intracellular multiplication of Legionella pneumophila serogroup 1In vitro activity of sparfloxacin (CI-978; AT-4140) for clinical Legionella isolates, pharmacokinetics in guinea pigs, and use to treat guinea pigs with L. pneumophila pneumonia.WIN 57273 is bactericidal for Legionella pneumophila grown in alveolar macrophagesClarithromycin: review of a new macrolide antibiotic with improved microbiologic spectrum and favorable pharmacokinetic and adverse effect profiles.Elevated levels of Legionella pneumophila stress protein Hsp60 early in infection of human monocytes and L929 cells correlate with virulencePulmonary disposition of roxithromycin (RU 28965), a new macrolide antibiotic.Effect of quinolones and other antimicrobial agents on cell-associated Legionella pneumophilaThe phagosomal environment protects virulent Mycobacterium avium from killing and destruction by clarithromycin.Characterization of a new region required for macrophage killing by Legionella pneumophilaInhibition of Legionella pneumophila multiplication within human macrophages by antimicrobial agents.Periplasmic copper-zinc superoxide dismutase of Legionella pneumophila: role in stationary-phase survivalAntimicrobial therapy of experimental Legionella micdadei pneumonia in guinea pigs.Environmental mimics and the Lvh type IVA secretion system contribute to virulence-related phenotypes of Legionella pneumophila.Antibiotic penetration of and bactericidal activity within endothelial cells.The iron superoxide dismutase of Legionella pneumophila is essential for viability.Cloning and nucleotide sequence of a gene (ompS) encoding the major outer membrane protein of Legionella pneumophilaCharacterization of a major 31-kilodalton peptidoglycan-bound protein of Legionella pneumophilaHigh-Throughput Intracellular Antimicrobial Susceptibility Testing of Legionella pneumophila.The Legionnaires' disease bacterium (Legionella pneumophila) inhibits phagosome-lysosome fusion in human monocytes.Formation of a novel phagosome by the Legionnaires' disease bacterium (Legionella pneumophila) in human monocytes.
P2860
Q28471800-2BBA2BCB-7F21-4E19-AE31-940085230C42Q28485637-5781062B-E862-43F2-A5D8-D1DA3314D88CQ28533449-15DCBD69-C380-4BAE-AB7D-E981E57B7F0DQ33241705-D0974A70-C1E1-4F36-B00E-B7898356CC42Q33243973-8A7B3AD3-C9D1-4C66-A9E1-4816B2D29CFAQ33311462-7C542DE4-7CE2-4E75-89FA-71D29553587BQ33459217-5C657A28-40C1-475E-8FAA-E170C2B95582Q33617859-0CAEE53C-45DB-461D-928C-C21C1907E7A2Q33737932-A118D4C1-9C59-41B3-A904-136650059B8BQ33744843-9D4DA648-4E1B-46BF-B9B6-C0161C8E7B70Q33763010-17DBA330-989D-480D-83B9-F15E0C8C80C0Q33792321-8703E1DB-103C-4117-AB4D-49283F4A3B90Q33935172-AD6A522A-CE31-47F5-9365-161AA4789FEBQ34164604-B79DD8C8-905D-455D-BAE7-51C4C7F49053Q34181343-AFE2DA02-5B27-4D5E-BD69-58F4B7A3FAB3Q34534352-F2AE2DCF-F904-4464-9A30-77D1F99E9534Q34570406-C8975016-D2A7-4571-89EA-ECD7F37033F0Q35038248-383B000B-3EAD-41C9-8B0A-D557CBC0B23BQ35165499-F7C313F3-A0CF-4B8D-9F58-4126239F2304Q35202685-D3672947-EAE0-4113-9C9C-358A4D5C0F33Q35272717-64A27395-DB30-4F74-A612-B9962DB64EF0Q35280841-14AA966E-9839-4D8A-AE62-7596CE10C250Q35364046-4128B658-8FF9-4653-9EA0-967633A33E17Q35466622-D4040717-C7DA-4DEB-B3DE-3023E5FD207CQ35495006-43068726-3E75-4217-B903-9883F6E6FB59Q35541320-184C8489-C58F-44A4-A450-6CD06CAC141BQ35542379-3E1E30BF-2CBC-47FA-B6C6-8A0377F1628DQ35551106-F991EF62-E09C-4E09-9B9E-C84EA9BF07ADQ35559956-DE2886C5-21A7-46CB-B578-8FF0CE086B36Q35575694-09942557-F8AE-4CA4-94AB-931C9E63628EQ35603832-2CA2F5DF-32D8-4CCD-AE72-1908F4B478FEQ35647845-8F847650-207F-4C31-8A18-8195B8A06324Q35689293-AC7AC189-08C6-4455-AFBD-17E08837AE3DQ35820549-7356CAE8-1EF5-4D08-887A-02E68FF044AAQ36108555-D2665CFC-E728-4D4D-8555-660F913674A3Q36113125-9071E19A-ED6C-4933-9944-52530E6754DAQ36162072-B1E97AC6-A02C-40D5-9ABE-C5833E8A5BA7Q36290493-D20D8115-0CCA-4CF3-8BC2-C3212C9B94DBQ36348251-14662F0E-B9B3-437C-90FB-05BBE21DAEC6Q36349063-C9A6767E-1536-4F39-A66F-E8C2908D98B9
P2860
Intracellular multiplication of Legionnaires' disease bacteria (Legionella pneumophila) in human monocytes is reversibly inhibited by erythromycin and rifampin
description
1983 nî lūn-bûn
@nan
1983 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1983 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1983年の論文
@ja
1983年論文
@yue
1983年論文
@zh-hant
1983年論文
@zh-hk
1983年論文
@zh-mo
1983年論文
@zh-tw
1983年论文
@wuu
name
Intracellular multiplication o ...... d by erythromycin and rifampin
@ast
Intracellular multiplication o ...... d by erythromycin and rifampin
@en
type
label
Intracellular multiplication o ...... d by erythromycin and rifampin
@ast
Intracellular multiplication o ...... d by erythromycin and rifampin
@en
prefLabel
Intracellular multiplication o ...... d by erythromycin and rifampin
@ast
Intracellular multiplication o ...... d by erythromycin and rifampin
@en
P2860
P356
P1476
Intracellular multiplication o ...... d by erythromycin and rifampin
@en
P2093
M A Horwitz
S C Silverstein
P2860
P356
10.1172/JCI110744
P407
P577
1983-01-01T00:00:00Z